CPRX
Catalyst Pharmaceuticals Inc
2 super-investors hold CPRX worth a combined $20M. The largest position: Third Avenue Management at 0.8% of their portfolio. This quarter the cohort logged 1 buy and 0 sells on the name. Cohort Conviction Score: 28 — ranked #458 of 724 scored stocks.
Why super-investors own CPRX
Super-investor interest in CPRX is minimal but marginally expanding: two managers in the cohort hold a combined $20M, and the owner count ticked up to two this quarter after Third Avenue Management initiated a new position worth roughly $5M, representing 0.8% of its portfolio — the highest concentration among holders. Joel Greenblatt carries the larger dollar position at $14M but at a negligible portfolio weight. Prior to this quarter, the cohort count had held at just one owner for eight consecutive quarters, making Third Avenue's entry the sole signal of incremental interest. At this scale and concentration, cohort conviction remains limited.
AI-synthesized from 13F filings. Not investment advice.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Joel Greenblatt | <0.1% | 34q | $14M | 581,093 |
| 2 | Third Avenue Management | 0.8% | — 1q | $5M | 210,161 |
Owners of CPRX also hold
Recent activity (1)
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Third Avenue Management | NEW | 0.8% | +100% | $5M | May 13, 2026 |
Long US equity 13F-HR filings only. CUSIP 14888U101. Not investment advice.